N-[4-(5-Oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine(CAS: 872728-82-0)

N-[4-(5-Oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine (CAS: 872728-82-0) falls under various regulatory guidelines including GHS classification for hazardous substances, REACH regulations for EU chemicals, and FDA and EPA requirements for pharmaceutical and environmental safety. Manufacturers and handlers should comply with these guidelines for proper labeling, storage, and disposal.

Synthesis alternatives to N-[4-(5-Oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine (CAS: 872728-82-0) include using analogs like N-[4-(1,2,4-oxadiazol-5-yl)phenyl]glycine or substituting with related compounds such as 5-oxo-1,2,4-oxadiazole derivatives. These alternatives may offer similar properties with potentially different synthesis routes and costs.

The market and research trends for N-[4-(5-Oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine (CAS: 872728-82-0) are focused on its applications in pharmaceuticals and as a research tool. There is an increasing demand for novel compounds with specific biological activities, driving further research into its potential therapeutic applications and synthesis methods.

Waste containing N-[4-(5-Oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine (CAS: 872728-82-0) should be collected in appropriate containers and disposed of via incineration or professional waste disposal services. Environmental protection measures should be followed to prevent contamination, and handlers should ensure compliance with local and international regulations regarding hazardous waste management.